Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
NCT06016946
This study is recruiting at 9 US sites in 8 states, according to its ClinicalTrials.gov record last updated .
Summary
This project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Friedreich Ataxia
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Any age
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Friedreich's Ataxia Research Alliance
- Last updated on ClinicalTrials.gov
- September 1, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- UCLA Ataxia Center · Los Angeles, CA
Colorado · 1
- University of Colorado · Denver, CO
Florida · 2
- University of Florida - Neurology · Gainesville, FL
- USF Ataxia Research Center · Tampa, FL
Georgia · 1
- Emory University Hospital - Neurology · Atlanta, GA
Iowa · 1
- University of Iowa, Stead Family Children's Hospital · Iowa City, IA
Ohio · 1
- Ohio State University - Neurology · Columbus, OH
Pennsylvania · 1
- Children's Hospital of Philadelphia · Philadelphia, PA
Tennessee · 1
- St. Jude Children's Research Hospital · Memphis, TN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.